Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.26 by 146.15 percent. This is a 68.32 percent decrease over earnings of $2.02 per share from the same period last year. The company reported quarterly sales of $401.300 million which beat the analyst consensus estimate of $364.343 million by 10.14 percent. This is a 34.33 percent decrease over sales of $611.091 million the same period last year.